LRMR

Larimar Therapeutics Inc

LRMR.US larimartx.com + Research + Basket
CIK 0001374690
Employees 71
Phone 844 511 9056
Fiscal year end December
IPO Jun 19, 2014
Address Three Bala Plaza East, Bala Cynwyd, PA, United States, 19004
2.32
-0.44 (-15.94%)
USD · NASDAQ
52-week range
1.92
6.42
Trading at 9% of the 52-week range
Market Cap
286.72M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
1.22
Div. Yield
N/A
% Institutions
95.06%
% Insiders
1.19%

1 Year

-28.0%

3 Year

-25.2%

10 Year

-93.8%
Description

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.

Actions

Add an action for LRMR.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Carole S. Ben-Maimon M.D. CEO & Director 1959
Mr. Michael Celano CPA Secretary & CFO 1959
Dr. Gopi Shankar M.B.A., Ph.D. Chief Development Officer 1971
Mr. John B. Harlow Jr. President & COO 1976
Mr. John Berman Vice President of Finance & Administration NA
Ms. Jennifer Spokes Johansson Vice President of Legal & Compliance NA
Dr. Russell G. Clayton Sr., D.O. Chief Medical Officer 1961
Mr. Francis Michael Conway CPA VP & Controller NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Feb 27, 2026 James E Flynn N/A Purchase 5.00M $5.00 $25.00M SEC
Jul 31, 2025 James E Flynn N/A Purchase 9.38M $3.20 $30.00M SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Deerfield Management Co 35.61M Jun 30, 2026 34.28% $1.13 0.00%
Blue Owl Capital Holdings LP 9.16M Jun 30, 2026 8.82% $4.21 28.70%
BlackRock Inc 5.68M Jun 30, 2026 5.47% $0.00 51.33%
Defilade Capital Management, L.P. 3.67M Jun 30, 2026 3.53% $1.50 0.00%
Driehaus Capital Management LLC 3.16M Jun 30, 2026 3.05% $0.06 7.80%
Vanguard Capital Management, LLC 2.97M Jun 30, 2026 2.86% $0.00 3.79%
RTW INVESTMENTS, LLC 2.57M Jun 30, 2026 2.47% $0.07 71.07%
AQR Capital Management LLC 2.37M Jun 30, 2026 2.28% $0.00 190.08%
Marshall Wace Asset Management Ltd 2.01M Jun 30, 2026 1.94% $0.00 115.59%
Dafna Capital Management LLC 2.01M Jun 30, 2026 1.93% $1.17 -1.03%
The Goldman Sachs Group Inc 1.75M Jun 30, 2026 1.69% $0.00 12.25%
Geode Capital Management, LLC 1.68M Jun 30, 2026 1.62% $0.00 51.43%
Qube Research & Technologies 1.64M Jun 30, 2026 1.58% $0.00 93.60%
Citadel Advisors Llc 1.46M Jun 30, 2026 1.40% $0.00 180.63%
State Street Corp 1.41M Jun 30, 2026 1.36% $0.00 54.92%
Vanguard Portfolio Management, LLC 1.40M Jun 30, 2026 1.35% $0.00 245.13%
Woodline Partners LP 1.40M Jun 30, 2026 1.35% $0.01 0.00%
Millennium Management LLC 1.33M Jun 30, 2026 1.28% $0.00 -63.23%
Dimensional Fund Advisors, Inc. 961.08K Jun 30, 2026 0.93% $0.00 20.37%
FMR Inc 937.37K Jun 30, 2026 0.90% $0.00 1,374.54%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 2.21M 2.12% ▲ 0.00% Sep 30, 2026
2 iShares Russell 2000 ETF 1.69M 1.62% ▼ 0.41% Oct 29, 2026
3 Fidelity Enhanced Small Cap Core ETF 1.01M 0.97% ▲ 0.27% Oct 29, 2026
4 Heptagon Driehaus US Micro Cap Eq C$ Acc 848.55K 0.82% ▲ 0.00% Sep 30, 2026
5 Fidelity Small Cap Index 726.52K 0.70% ▲ 0.38% Jul 31, 2026
6 Vanguard Explorer Inv 659.13K 0.63% ▲ 0.00% Sep 30, 2026
7 iShares Russell 2000 Growth ETF 634.73K 0.61% ▲ 0.25% Oct 29, 2026
8 MEDICAL BioHealth EUR Acc 521.55K 0.50% ▲ 0.02% Aug 31, 2026
9 Vanguard Russell 2000 ETF 388.42K 0.37% ▲ 1.30% Sep 30, 2026
10 iShares Biotechnology ETF 375.25K 0.36% ▼ 0.19% Oct 29, 2026

Financial Highlights

▼
Market Cap: $286.72M
EBITDA: $-178.68M
Book Value: $1.22
Earnings/Share: $-1.99
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -70.96%
ROE (TTM): -139.63%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $113.59M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 103.88M
Shares Float: 57.90M
% Insiders: 1.19%
% Institutions: 95.06%
Shares Short: 14.66M
Shares Short (Prior Month): 15.37M
Short Ratio: 8.72
Short % Float: 21.80%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-350.00K
Gross Profit
subtotal
$-350.00K
SG&A
adjust
$-18.27M
R&D
adjust
$-154.22M
Operating Income
subtotal
$-172.50M
Other / Non-Operating Items
adjust
$6.82M
Net Income
subtotal
$-165.67M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about LRMR.US!